Eubel Brady & Suttman Asset Management Inc Zoetis Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

$691 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 05, 2021	SELL	$189.29 - $209.69 $55,840 - $61,858	-295 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$155.9 - $187.99 $45,990 - $55,457	295 New	295 $46,000

Others Institutions Holding ZTS

# of Institutions

1,923

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

Vanguard Group Inc Valley Forge, PA

41.2M
Shares

$7.37 Billion
0.14% of portfolio
Black Rock Inc. New York, NY

36.8M
Shares

$6.59 Billion
0.15% of portfolio
State Street Corp Boston, MA

19.7M
Shares

$3.52 Billion
0.15% of portfolio
State Farm Mutual Automobile Insurance CO Bloomington, IL

16.2M
Shares

$2.89 Billion
2.53% of portfolio
Bank Of America Corp Charlotte, NC

15.1M
Shares

$2.7 Billion
0.23% of portfolio

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Account